Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adi Wilf-Yarkoni

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Epilepsia|June 23, 2023
Investigation of cardiac arrhythmia events in patients treated with lamotrigine: FDA adverse event reporing system analysisMohammed Aboukaoud, Adi Wilf-Yarkoni, Elad Maor
Neurology(R) Neuroimmunology & Neuroinflammation|July 16, 2020
High κ free light chain is a potential biomarker for double seronegative and ocular myasthenia gravisAdi Wilf-Yarkoni, Yifat Alkalay, Talma Brenner, et al.
Journal of Neurology|October 16, 2020
Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic reviewItay Lotan, Mark A Hellmann, Adi Wilf-Yarkoni, et al.
Journal of Neurology|April 8, 2021
Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravisAdi Wilf-Yarkoni, Itay Lotan, Israel Steiner, et al.
Multiple Sclerosis and Related Disorders|March 27, 2024
Association between clinical characteristics, acute steroid treatment and oligoclonal bands result in multiple sclerosis: A retrospective studyAssaf Tolkovsky, Keshet Pardo, Mark Hellmann, et al.
Journal of the Neurological Sciences|June 6, 2022
Repeated lumbar puncture in search of oligoclonal bands - What is the yield?Maor Mermelstein, Jonathan Naftali, Adi Wilf-Yarkoni, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 11, 2014
Cognitive function and other non-motor features in non-demented Parkinson's disease motor subtypesTalia Herman, Aner Weiss, Marina Brozgol, et al.
Journal of Neurology|July 9, 2025
Familial myasthenia gravis: characterization of an Israeli cohort and systematic review of the literatureMark A Hellmann, Israel Steiner, Maor Mermelstein, et al.
Neuromuscular Disorders : NMD|March 1, 2022
Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravisItay Lotan, Mark A Hellmann, Yitzhak Friedman, et al.
European Journal of Neurology|July 21, 2021
Safety of the BNT162b2 COVID-19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in IsraelItay Lotan, Adi Wilf-Yarkoni, Yitzhak Friedman, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Epilepsia|June 23, 2023
Investigation of cardiac arrhythmia events in patients treated with lamotrigine: FDA adverse event reporing system analysisMohammed Aboukaoud, Adi Wilf-Yarkoni, Elad Maor
Neurology(R) Neuroimmunology & Neuroinflammation|July 16, 2020
High κ free light chain is a potential biomarker for double seronegative and ocular myasthenia gravisAdi Wilf-Yarkoni, Yifat Alkalay, Talma Brenner, et al.
Journal of Neurology|October 16, 2020
Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic reviewItay Lotan, Mark A Hellmann, Adi Wilf-Yarkoni, et al.
Journal of Neurology|April 8, 2021
Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravisAdi Wilf-Yarkoni, Itay Lotan, Israel Steiner, et al.
Multiple Sclerosis and Related Disorders|March 27, 2024
Association between clinical characteristics, acute steroid treatment and oligoclonal bands result in multiple sclerosis: A retrospective studyAssaf Tolkovsky, Keshet Pardo, Mark Hellmann, et al.
Journal of the Neurological Sciences|June 6, 2022
Repeated lumbar puncture in search of oligoclonal bands - What is the yield?Maor Mermelstein, Jonathan Naftali, Adi Wilf-Yarkoni, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 11, 2014
Cognitive function and other non-motor features in non-demented Parkinson's disease motor subtypesTalia Herman, Aner Weiss, Marina Brozgol, et al.
Journal of Neurology|July 9, 2025
Familial myasthenia gravis: characterization of an Israeli cohort and systematic review of the literatureMark A Hellmann, Israel Steiner, Maor Mermelstein, et al.
Neuromuscular Disorders : NMD|March 1, 2022
Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravisItay Lotan, Mark A Hellmann, Yitzhak Friedman, et al.
European Journal of Neurology|July 21, 2021
Safety of the BNT162b2 COVID-19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in IsraelItay Lotan, Adi Wilf-Yarkoni, Yitzhak Friedman, et al.
Pageof 4